Company

LabGenius Therapeutics

Biotechnology Research London, City of, United Kingdom 66 employees

Employees: 66
Contacts: 2
Emails: 2
Phones: 2

www.labgeniustx.com LinkedIn

LabGenius Therapeutics Overview

Headquarters: London, City of, United Kingdom
Website: www.labgeniustx.com
Industry: Biotechnology Research
Employees: 66
Founded: 2012
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Medical Health DNA Libraries

About LabGenius Therapeutics

LabGenius Therapeutics ("LabGenius") is a drug discovery company pioneering the discovery of next-generation therapeutic antibodies. The company’s discovery platform, EVA™, integrates several cutting-edge technologies drawn from the fields of artificial intelligence, robotic automation and synthetic biology. While EVA™ is both modality and format-agnostic, LabGenius' internal pipeline is focussed on the development of selectivity-enhanced antibodies for the treatment of solid tumours. The company's novel approach is delivering a pipeline of antibody therapeutics with best-in-class killing profiles.

LabGenius Therapeutics Contact Details

People in AeroLeads: 4
With contact data: 2
Email contacts: 2; 50.0% coverage
Phone contacts: 2; 50.0% coverage

LabGenius Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Angus Sinclair	Cso	San Francisco Bay Area, United States	Email Phone
Leila Rastegar Zegna	Founding General Partner at Kindred Capital	London, England, United Kingdom	Email Phone
Edwin Moses	Chairman of the Board at Labgenius Ltd, Dark Blue Therapeutics Ltd, Nanosyrinx Ltd and Avantium Nv		View
Nan Li		San Francisco, California, United States	View